Table 2.
EV-associated ncRNAs in liver disease.
| ncRNAs | Expression | Liver disease | Function | Citation |
|---|---|---|---|---|
| miR-122 | Up | HCV | Biomarker | Bihrer et al., 2011 |
| miR-192 | Up | AH | Diagnostic markers | Ghidini and Braconi, 2015 |
| miR-21 | Up | HCC | Inhibitor apoptosis | Gomaa et al., 2008 |
| miR-18a | Up | HCC | Promotes cell proliferation | Sohn et al., 2015 |
| miR-221 | Up | HCC | Promotes growth and invasion of cells | Sohn et al., 2015 |
| miR-222 | Up | HCC | Promoters proliferation | Sohn et al., 2015 |
| linc-VLDLR | Up | HCC | Promotes chemoresistance | Giroud and Scheideler, 2017 |
| linc-RoR | Up | HCC | Promotes tumor | Loewer et al., 2010; Nath and Szabo, 2012 |
| miR-718 | Down | HCC | Inhibitor proliferation | Sugimachi et al., 2015 |
| miR-199a | Down | HCV | Inhibitor of HCV transmission | El-Abd et al., 2015 |
| miR-30a | Up | AH | Potential diagnostic markers | Momen-Heravi et al., 2015 |
| miR-122 | Up | NASH | Biomarker | Miyaaki et al., 2014 |
| miR-182 | Up | AH | Increases inflammatory mediators | Blaya et al., 2016 |
| miR-193b | Down in HCC, up in HCV-HCC | HCC HBV-HCC | Diagnostic tool/biomarker | Braconi et al., 2010; Mao et al., 2014 |